SLI
2.125,85
PKT
-62,92
PKT
-2,87
%
Werbung
Analysen zu SLI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 18.04.05 | Novartis Outperform | Goldman Sachs | |
| 18.04.05 | Helvetia Baloise Accumulate | Helvea | |
| 19.04.05 | Roche Equal weight | Lehman Brothers | |
| 19.04.05 | Novartis Neutral | JP Morgan | |
| 18.04.05 | Helvetia Baloise Sector Outperform | Vontobel | |
| 19.04.05 | Roche Overweight | JP Morgan | |
| 18.04.05 | UBS Market Perform | Vontobel | |
| 18.04.05 | UBS Market Outperform | Vontobel | |
| 18.04.05 | Nestlé Neutral | Sarasin Research | |
| 15.04.05 | Novartis Kaufen | Helaba Trust | |
| 19.04.05 | Helvetia Baloise Buy | Sarasin Research | |
| 15.04.05 | Roche In-Line | Goldman Sachs | |
| 18.04.05 | Novartis Neutral | Sarasin Research | |
| 18.04.05 | Roche Buy | Sarasin Research | |
| 18.04.05 | Novartis Neutral | HypoVereinsbank | |
| 15.04.05 | Roche In-Line | Goldman Sachs | |
| 18.04.05 | Roche Outperform | HypoVereinsbank | |
| 18.04.05 | Roche Buy | Helvea | |
| 14.04.05 | Novartis Reduce | UBS | |
| 14.04.05 | Novartis Reduce | UBS | |
| 14.04.05 | ABB (Asea Brown Boveri) Overweight | Lehman Brothers | |
| 14.04.05 | Roche Halten | Helaba Trust | |
| 15.04.05 | Novartis Underperform | Credit Suisse First Boston | |
| 15.04.05 | Roche Buy | SES Research | |
| 13.04.05 | Lonza Reduce | Sarasin Research | |
| 13.04.05 | Novartis Neutral | Sarasin Research | |
| 13.04.05 | Logitech Neutral | Sarasin Research | |
| 11.04.05 | Givaudan Neutral | Helvea | |
| 11.04.05 | Richemont Accumulate | Helvea | |
| 11.04.05 | Lonza Overweight | JP Morgan | |
| 11.04.05 | Givaudan Neutral | Sarasin Research | |
| 11.04.05 | Richemont Buy | Sarasin Research | |
| 11.04.05 | Zurich Insurance Neutral | JP Morgan | |
| 11.04.05 | Givaudan Equal weight | Lehman Brothers | |
| 11.04.05 | Swiss Life Akkumulieren | Nord LB | |
| 11.04.05 | Givaudan Underperform | HypoVereinsbank | |
| 08.04.05 | Novartis Accumulate | Helvea | |
| 08.04.05 | Zurich Insurance Sector Outperform | Vontobel | |
| 08.04.05 | Swiss Life Underperformer | LB Rheinland-Pfalz | |
| 08.04.05 | Givaudan Neutral | Helvea |